Zhou L, Peng L. Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis. J Med Biochem [Internet]. 2025 Sep. 1 [cited 2026 Jul. 12];45(3):529-38. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/60451